// App-Quantinova.ai

649 : COVID-19 in Patients (pts) with Chronic Myeloid Leukemia (CML): Results from the International CML Foundation (iCMLf) CML and COVID-19 (CANDID) Study

Researchers

Presenter

  • Delphine Rea

Principal Investigators

  • Michael J. Mauro

  • Jorge E. Cortes

  • Qian Jiang

  • Katia B Pagnano

  • Matilda Ongondi

  • Chung Hoow Kok

  • Nicola Evans

  • Timothy P. Hughes

Medical Centers

  • Université de Paris, Hematology department, Saint-Louis hospital, APHP, Paris, France

  • Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, New York

  • Georgia Cancer Center, Augusta University, Augusta, GA

  • Peking University People's Hospital, Beijing, China

  • State University Campinas, Campinas, Brazil

  • Kenyatta National Hospital, Nairobi, Kenya

  • Cancer Program, Precision Medicine Theme,South Australian Health and Medical Research Institute,Adelaide,Australia

  • International CML Foundation, Adelaide, SA, Australia

  • South Australian Health and Medical Research Institute, Adelaide, Australia

  • iCMLf, Bexhill-On-Sea, United Kingdom

Locations

  • France

  • United States

  • China

  • Brazil

  • Australia

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Chronic Myelogenous Leukemia

  • Coronavirus disease

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved